Postbiotics and prebiotics for the skin: Dermala unveils skin microbiome balancing oat NPD
31 Aug 2021 --- The skin’s microbiome importance for skin health is increasingly recognized. With this in mind, Dermala is launching a soothing daily moisturizer for blemish-prone skin, called OAT So Sweet, formulated with prebiotics and postbiotics.
The product is a combination of ingredients that was specifically formulated to help calm, restore, and heal acne-prone skin. OAT So Sweet Daily Moisturizer is suitable for any skin type and reduces redness while hydrating and protecting the skin.
“Customers are achieving success in treating their acne with our #FOBO (Fear of Breaking Out) Acne Treatment Kit,” says Lada Rasochova, Ph.D., founder and CEO of Dermala.
“OAT So Sweet moisturizer compliments the #FOBO Kit regimen and is built to calm, hydrate, and heal acne-prone skin.”
Trending microbiome NPD
According to Innova Market Insights, microbiome personal care products are gaining momentum as they respond to consumer demands for safety, naturality and effectiveness.
The product is a combination of ingredients that was specifically formulated to help calm, restore, and heal acne-prone skin.
Personal care products that feature a prebiotic and/or probiotic claim have witnessed an average annual growth of 73 percent these past five years (Global, CAGR 2016-2020).
OAT So Sweet Daily Moisturizer hydrates and plumps the skin without clogging pores, supports the company. It features key ingredients such as colloidal oatmeal, niacinamide, licorice root extract, ceramides, avocado oil and green tea leaf extract.
The patented SE Microbiome Complex and SE Sugar Complex are the true differentiators of this moisturizer, providing naturally occurring prebiotics and postbiotics.
These support a balanced microbiome by killing C. acnes, the acne-causing bacteria, while promoting the growth of S. epidermidis, the healthy, acne-fighting bacteria.
Microbiome science
All Dermala products are based on human microbiome science and are formulated with patented microbiome-derived prebiotics, probiotics and postbiotics that improve skin health naturally by balancing both the skin and gut microbiome.
The company’s #FOBO Kit, a personalized, microbiome-powered solution for acne, combines patented topical acne treatments and oral supplements with the Dermala Acne Tracker app that customers use to track their skin health and get product formulations continuously optimized based on their results.
In the same space, Florajen Probiotics recently launched its first skin health product, Florajen Eczema, a refrigerated medical food that is clinically shown to reduce atopic dermatitis, commonly referred to as eczema.
Personal care products featuring a prebiotic and/or probiotic claim have risen 73 percent (Global, CAGR 2016-2020).Moreover, Florajen Eczema has been shown to improve symptoms of eczema and reduce reliance on steroidal topical treatments in a clinical trial conducted at the Esthetic Dermatology Center in Spain.
Skin microbiome moves
As awareness on the importance of the skin microbiome rises many players are tapping into its potential. For example, Givaudan’s personal care arm Givaudan Active Beauty unveiled the “world’s first” instant microbiome analysis and profiling system, coined i-MAPS.
The company also launched Mangixyl, a microbiome-friendly ingredient that targets oily skin through sebum regulation.
The technology allows Givaudan’s customers to expand their product offerings to include skincare products that are tailored to the unique microbiome of their consumers.
DSM Venturing, the venture investment arm of DSM Nutrition, previously made an equity investment in skin microbiome company S-Biomedic NV. This move completes S-Biomedic’s latest series A financing round.
Meanwhile, multinational pharmaceutical Bayer and Azitra, a clinical-stage medical dermatology biotech company partnered in research to identify and characterize skin microbiome bacteria. The move seeks to uncover the skin microbiome’s potential in helping to develop skincare products for adverse skin conditions and diseases, such as eczema.
By Kristiana Lalou
